- Lobbying
- Nick AND Littlefield
Lobbying Arrangements Results for 'Nick Littlefield'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Food and Drug Legislation |
Abbott
pharmaceutical company |
FOLEY HOAG LLP | |||
Details Medicaid waivers |
Boston Medical Center
|
FOLEY HOAG LLP | |||
Details pandemic influenza biodefense preparedness |
Kleiner Perkins Caulfield & Byers
venture capital firm |
FOLEY HOAG LLP | |||
Details Food and Drug Legislation |
Sanofi-Aventis, U.S. LLC
pharmaceutical company |
FOLEY HOAG LLP | |||
Details Vaccine legislation |
NOVARTIS VACCINES AND DIAGNOSTICS, INC.
|
FOLEY HOAG LLP | |||
Details Implementation of pandemic and biodefense preparedness legislation. |
Adamas Pharmaceuticals
|
FOLEY HOAG LLP | |||
Details Issues relating to Section 3026 of the Affordable Care Act. |
Dovetail Health
|
FOLEY HOAG LLP | |||
Details Cancer legislation issues |
Susan G. Komen Breast Cancer Foundation
Non-for-profit breast cancer patient and survivor advocacy group |
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (H.R. 3590); Health Care and Education Affordability Reconciliation Act (H.R. 4872) |
Bristol-Myers Squibb
|
FOLEY HOAG LLP | |||
Details Patent Reform - S 1145, HR 1908 FDA Globalization Act - HR 3610, S 3409 Follow-on Biologics -- S 1695, HR 1038, HR 1956 Physician Payments Sunshine Act: S 2029 |
BIOGEN IDEC, INC.
|
FOLEY HOAG LLP | |||
Details Medicare payment for clinical diagnostics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148)(Section 3113); Budget Control Act of 2011 (P.L. 112-25) |
XDx, Inc.
Molecular diagnostics |
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Prevention and wellness provisions |
Inverness Medical Innovations
|
FOLEY HOAG LLP | |||
Details H.R. 4808 (Stem Cell Research Advancement Act of 2009) |
Advanced Cell Technology
|
FOLEY HOAG LLP | |||
Details S.___ Affordable Healthy Futures Act; America's Affordable Health Choices Act H.R.3200; Follow-on Biologics - H.R. 1427, H.R. 1548 |
Genentech, Inc.
|
FOLEY HOAG LLP | |||
Details Medicare Coverage and Reimbursement Health Care Reform Follow-on Biologics |
PFIZER INC.
|
FOLEY HOAG LLP | |||
Details Medicare Payment for Diabetes screening; Healthcare Reform and Prevention |
Tethys Bioscience
|
FOLEY HOAG LLP | |||
Details Congressional deficit reduction negotiations and Deficit Reduction Commission, following passage of the Budget Control Act of 2011 (P.L. 112-25) |
ASTRAZENECA PHARMACEUTICALS LP
|
FOLEY HOAG LLP | |||
Details H.R. 307, Pandemic and All Hazards Preparedness Reauthorization Act; and Implementation of Project BioShield Act. Implementation of the American Taxpayer Relief Act of 2012 Pub.L. 112240, H.R. 8 S.... |
Chimerix, Inc.
|
FOLEY HOAG LLP | |||
Details Medicare drug reimbursement |
Optimer Pharmaceuticals, Inc.
Pharmaceutical company |
FOLEY HOAG LLP | |||
Details S. 3187 Food and Drug Administration Safety and Administration Act H.R. 5651 Food and Drug Administration Reform Act Work to educate Congress on telehealth and telemedicine issues in the Prescripti... |
Teladoc, Inc.
|
FOLEY HOAG LLP | |||
Details MODDERN Cures Act, H.R. 3091 and H.R. 3116. |
Eli Lilly and Company
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) |
State of the USA
|
FOLEY HOAG LLP | |||
Details Implementation of the Affordable Care Act of 2010 (Pub. L. 111-148) Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152) Implementation of the Food and Drug Administration Safet... |
CUBIST PHARMACEUTICALS
|
FOLEY HOAG LLP | |||
Details Colorectal Cancer Medicare and Reimbursement Issues; Screen Act--S. 1511 Supporting Colorectal Examination Now Act; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Health Ca... |
American College of Gastroenterology
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148); Health Care and Education Reconciliation Act (P.L. 111-152) Medicare Orthotics and Prosthetics Improvement Act (H.R.1958); Insurance Fairn... |
American Orthotic & Prosthetic Association
|
FOLEY HOAG LLP | |||
Details Matters affecting research, diagnosis, treatment and prevention of breast cancer, including 21st Century Cancer Alert Act Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148); Healt... |
Susan G. Komen For The Cure
Non-for-profit breast cancer patient and survivor advocacy group |
FOLEY HOAG LLP | |||
Details Patent Reform Legislation - S 515, HR 1260 FDA Globalization Act - HR 759 Follow-on biologics - HR1427, HR 1548 Physician Payments Sunshine Act - S 301 ARRA; CER Medicare Improvements for Patients ... |
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
|
FOLEY HOAG LLP | |||
Details -Medicare payment and coding for clinical laboratory tests -Implementation of Protecting Access to Medicare Act of 2014 (P.L. 113-93) -Regulation of molecular diagnostics -Issues relating to Cure... |
Coalition for the 21st Century
|
FOLEY HOAG LLP | |||
Details S.___ Affordable Healthy Futures Act; Americas Affordable Health Choices Act H.R.3200. The Patient-Centered Outcomes Research Act, S.1213; Comparative effectiveness research H.R.2505; Implementatio... |
GlaxoSmithKline
pharmaceutical company |
FOLEY HOAG LLP | |||
Details Medicare Part D Prescription Drug Benefit; Medicare coverage policy for chronic renal disease; Medicare Part B payment and coverage of dialysis products; Congressional deficit reduction negotiatio... |
AMGEN
|
FOLEY HOAG LLP | |||
Details Patient Protection and Affordable Care Act (P.L. 111-148) Health Care and Education Reconciliation Act (P.L. 111-152) (Delivery System Reforms) |
Partners HealthCare System
|
FOLEY HOAG LLP | |||
Details Preserve Access to Affordable Generics Act - S.369 Patent Reform Act - S.515 Patient Protection and Affordable Care Act - H.R.3590 Affordable Health Care for America Act - HR 3962 Pathway for Bios... |
Eisai Corporation of North America
|
FOLEY HOAG LLP | |||
Details Medicare payment for biologics; Patient Protection and Affordable Care Act of 2010 (Pub. L. 111-148) (Delivery reforms) H.R. 1862 Regenerative Medicine Promotion Act of 2011; Budget Control Act of ... |
Organogenesis Inc.
Regenerative medicine company. |
FOLEY HOAG LLP | |||
Details Pending healthcare legislation and potential impact on the biopharmaceutical industry. Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing an... |
GILEAD SCIENCES, INC
|
FOLEY HOAG LLP | |||
Details -Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development ... |
Sanofi US Services, Inc.
|
FOLEY HOAG LLP | |||
Details |
CATAPULT LEARNING
|
FOLEY HOAG LLP |